Viewing Study NCT06011733


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-05-10 @ 4:13 PM
Study NCT ID: NCT06011733
Status: COMPLETED
Last Update Posted: 2025-03-10
First Post: 2023-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Plaque Psoriasis View
None Moderate to Severe Chronic Plaque Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Psoriasis View
None PSO View
None Bimekizumab View
None Chinese Adults Study Participants View